Clinical Trial Update: 18F-FLUC PET/MR in Patients With Brain Mets [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating 18F-FLUC PET/MR imaging in patients with brain metastases is currently recruiting. Sponsor is University of Wisconsin, Madison.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• 18F-FLUC PET/MR tracer

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Brain Metastasis, Radiation Therapy | Phase 3 | Status: RECRUITING